Here are four things to know:
1. Emory Orthopaedics & Spine Center Director Scott D. Boden, MD, will serve as the principal investigator.
2. The researchers will compare traditional cortisone injection outcomes to autologous bone marrow concentrate stem cell injection. They will also assess manufactured stem cells from umbilical cord tissue and adipose-derived stem cells.
3. Other organizations participating in the study include:
- Sioux Falls, S.D.-based Sanford Health
- Durham, N.C.-based Duke University
- Gulf Breeze, Fla.-based Andrews Institute for Orthopaedics & Sports Medicine
- Atlanta-based Georgia Institute of Technology
4. The Emory Orthopaedics & Spine Center employs 24 physicians across nine locations.
More articles on biologics:
Bone Biologics raises $5.9M: 3 notes
Viscogliosi Brothers to purchase Bioventus’ BMP development program: 5 insights
3 things to know about Ortho RTi
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
